Described are derivatives with an adrenergic antagonistic activity and, in particular, high selectivity for &agr;
1a
- and &agr;
1d
-adrenergic receptors compared to &agr;
1b
-receptors. This selectivity profile suggests the use of these derivatives in the treatment of symptoms of the lower urinary tract, including those associated to benign prostatic hyperplasia, without the side effects associated with hypotensive activity.
描述了具有
肾上腺素拮抗活性的衍
生物,特别是相对于α1b-受体具有较高选择性的α1a-和α1d-
肾上腺素受体。这种选择性配置表明这些衍
生物可用于治疗下尿路症状,包括与良性前列腺增生相关的症状,而不会出现与降压活性相关的副作用。